Designing Potent, Orally Available Cyclic Peptides as GPCR Modulators

  • Accelerate GPCR structural determination and structure-based drug design with Cryo-EM combined with GPCR conformational stabilization.
  • Integrate free-state and receptor-bound conformational data to engineer high-affinity macrocyclic peptides as GPCR modulators.
  • Apply two complementary strategies to achieve oral bioavailability in preclinical animals